Roivant Sciences Ltd. (NASDAQ: ROIV) reported Q3 EPS of ($0.38), $0.07 worse than the analyst estimate of ($0.31). Revenue for the quarter came in at $1.99 million versus the consensus estimate of $5.13 million.

For earnings history and earnings-related data on Roivant Sciences Ltd. (ROIV) click here.